Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2003-08-18
2009-10-06
Dentz, Bernard (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
active
07598377
ABSTRACT:
The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, use of the selective inhibitors in anti-thrombotic therapy, and a method for screening compounds useful for the new anti-thrombotic therapy by detecting selective inhibitory activity of PI 3-kinase β of the compound. The invention also relates to novel compounds that are inhibitors of PI 3-kinase.
REFERENCES:
patent: 5703075 (1997-12-01), Gammill et al.
patent: 6977255 (2005-12-01), Robertson et al.
patent: 7405211 (2008-07-01), Robertson et al.
patent: WO 0153266 (2001-07-01), None
Abbott Belinda
Anderson Karen
Goncalves Isaac
Jackson Shaun P.
Kenche Vijaya
AstraZeneca AB
Dentz Bernard
Pepper Hamilton LLP
LandOfFree
Inhibition of phosphoinositide 3-kinase β does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of phosphoinositide 3-kinase β, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of phosphoinositide 3-kinase β will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4105584